In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni announce regulatory milestones, secure new funding, appoint new executives, and much more on the road to LSI USA ‘25 in Dana Point, CA (March 17-21).
Achieved FDA clearance for its Small Body Array to be used with the Siemens Healthineers Magnetom 1.5T platform. The lightweight, ultra-flexible MRI coils are designed to enhance diagnostic accuracy and patient comfort by conforming to each patient’s anatomy.
Welcomed Dr. Mark Froimson, MD, MBA, as its new Chief Executive Officer, transitioning from his role as Chairman of the Board. Founder Eugene Malinskiy, the creator of the ArthroFree wireless surgical camera, has assumed the position of Chief Product and Technology Officer to focus on developing next-generation ArthroFree innovations.
Secured funding from the Claret European Growth Capital Fund III (CEGCF III) to further develop its product portfolio and expand its presence in the U.S. market. The investment will bolster Neurent Medical’s efforts to bring its pioneering ENT solutions to more patients globally.
Received FDA Investigational Device Exemption (IDE) approval to conduct a pivotal trial for the JuxtaFlow Renal Assist Device (RAD). This trial marks a critical step in validating the safety and effectiveness of its innovative renal therapy designed to enhance outcomes for patients with kidney disease.
Stay tuned for more updates, insights, and achievements of our LSI Alumni in The Weekly Recap, and follow our blog for the latest medical device news and advancements.
Schedule an exploratory call
Request Info© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
